与未使用降脂药物相比，使用他汀类药物治疗的外周动脉疾病且血清低密度脂蛋白胆固醇≥125mg/dl的老年人中新发冠状动脉事件的发生率。 - Suppr

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.

作者信息

Aronow Wilbert S, Ahn Chul

机构信息

Cardiology Division, Department of Medicine,Westchester Medical Center/New York Medical College, Valhalla, New York, USA.

出版信息

Am J Cardiol. 2002 Oct 1;90(7):789-91. doi: 10.1016/s0002-9149(02)02616-4.

DOI:10.1016/s0002-9149(02)02616-4

PMID:12356403

Abstract

摘要

相似文献

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.与未使用降脂药物相比，使用他汀类药物治疗的外周动脉疾病且血清低密度脂蛋白胆固醇≥125mg/dl的老年人中新发冠状动脉事件的发生率。

Am J Cardiol. 2002 Oct 1;90(7):789-91. doi: 10.1016/s0002-9149(02)02616-4.

Incidence of new coronary events in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.曾发生心肌梗死且血清低密度脂蛋白胆固醇≥125mg/dl的老年人，接受他汀类药物治疗与未接受降脂药物治疗相比，新发冠状动脉事件的发生率。

Am J Cardiol. 2002 Jan 1;89(1):67-9. doi: 10.1016/s0002-9149(01)02167-1.

Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.冠心病患者与对照受试者中他汀类药物（阿托伐他汀、氟伐他汀、洛伐他汀、普伐他汀和辛伐他汀）对空腹和餐后脂蛋白影响的比较。

Am J Cardiol. 2004 Jan 1;93(1):31-9. doi: 10.1016/j.amjcard.2003.09.008.

Comparative efficacy and tolerability of low-dose pravastatin versus lovastatin in patients with hypercholesterolemia.低剂量普伐他汀与洛伐他汀治疗高胆固醇血症患者的疗效及耐受性比较

Am Heart J. 1999 Mar;137(3):458-62. doi: 10.1016/s0002-8703(99)70492-8.

Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.瑞舒伐他汀与阿托伐他汀、辛伐他汀及普伐他汀对高胆固醇血症患者非高密度脂蛋白胆固醇、载脂蛋白及脂质比值的影响：STELLAR试验的额外结果

Clin Ther. 2004 Sep;26(9):1388-99. doi: 10.1016/j.clinthera.2004.09.006.

Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.降低血脂以降低冠状动脉疾病风险的指南：瑞舒伐他汀与阿托伐他汀、普伐他汀和辛伐他汀在实现降脂目标方面的比较。

Am J Cardiol. 2003 Mar 6;91(5A):11C-17C; discussion 17C-19C. doi: 10.1016/s0002-9149(03)00004-3.

Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial.在MERCURY I试验中，瑞舒伐他汀与阿托伐他汀、辛伐他汀和普伐他汀在实现胆固醇目标及改善伴有或不伴有代谢综合征的高胆固醇血症患者血脂方面的比较。

Diabetes Obes Metab. 2005 Jul;7(4):430-8. doi: 10.1111/j.1463-1326.2004.00450.x.

Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).阿托伐他汀与辛伐他汀、普伐他汀、洛伐他汀及氟伐他汀治疗高胆固醇血症患者的比较剂量疗效研究（CURVES研究）

Am J Cardiol. 1998 Mar 1;81(5):582-7. doi: 10.1016/s0002-9149(97)00965-x.

Tolerability and effects on lipids of ezetimibe coadministered with pravastatin or simvastatin for twelve months: results from two open-label extension studies in hypercholesterolemic patients.依折麦布与普伐他汀或辛伐他汀联合使用十二个月的耐受性及对血脂的影响：两项高胆固醇血症患者开放标签扩展研究的结果

Clin Ther. 2008 Dec;30(12):2280-97. doi: 10.1016/j.clinthera.2008.12.008.

Am J Cardiol. 1998 Aug 1;82(3):406-7.

引用本文的文献

A Non-Coronary, Peripheral Arterial Atherosclerotic Disease (Carotid, Renal, Lower Limb) in Elderly Patients-A Review PART II-Pharmacological Approach for Management of Elderly Patients with Peripheral Atherosclerotic Lesions outside Coronary Territory.老年患者的非冠状动脉外周动脉粥样硬化疾病（颈动脉、肾动脉、下肢）——综述第二部分——冠状动脉以外区域外周动脉粥样硬化病变老年患者的药物治疗方法

J Clin Med. 2024 Mar 5;13(5):1508. doi: 10.3390/jcm13051508.

Statins and Peripheral Arterial Disease: A Narrative Review.他汀类药物与外周动脉疾病：一篇叙述性综述

Front Cardiovasc Med. 2021 Nov 22;8:777016. doi: 10.3389/fcvm.2021.777016. eCollection 2021.

Drug Therapy of Dyslipidemia in the Elderly.老年人血脂异常的药物治疗

Drugs Aging. 2019 Apr;36(4):321-340. doi: 10.1007/s40266-018-00632-x.

The burden and characteristics of peripheral arterial disease in patients undergoing amputation in Korle Bu Teaching Hospital, Accra, Ghana.加纳阿克拉科尔勒布教学医院接受截肢手术患者的外周动脉疾病负担及特征

Ghana Med J. 2017 Sep;51(3):108-114. doi: 10.4314/gmj.v51i3.3.

Medical Therapy in Peripheral Artery Disease and Critical Limb Ischemia.外周动脉疾病和严重肢体缺血的药物治疗

Curr Treat Options Cardiovasc Med. 2016 Jul;18(7):42. doi: 10.1007/s11936-016-0464-8.

Do the Effects of Secondary Prevention of Cardiovascular Events in PAD Patients Differ from Other Atherosclerotic Disease?外周动脉疾病（PAD）患者心血管事件二级预防的效果与其他动脉粥样硬化性疾病有差异吗？

Int J Mol Sci. 2015 Jun 25;16(7):14477-89. doi: 10.3390/ijms160714477.

Lipid-lowering therapy in older persons.老年人的降脂治疗。

Arch Med Sci. 2015 Mar 16;11(1):43-56. doi: 10.5114/aoms.2015.48148. Epub 2015 Jan 8.

Use of statins in lower extremity artery disease: a review.他汀类药物在下肢动脉疾病中的应用：综述

BMC Surg. 2012;12 Suppl 1(Suppl 1):S15. doi: 10.1186/1471-2482-12-S1-S15. Epub 2012 Nov 15.

Peripheral arterial disease of the lower extremities.下肢外周动脉疾病。

Arch Med Sci. 2012 May 9;8(2):375-88. doi: 10.5114/aoms.2012.28568.

Low-density lipoprotein lowering does not improve calf muscle perfusion, energetics, or exercise performance in peripheral arterial disease.降低低密度脂蛋白并不能改善周围动脉疾病患者的小腿肌肉灌注、能量代谢或运动表现。

J Am Coll Cardiol. 2011 Aug 30;58(10):1068-76. doi: 10.1016/j.jacc.2011.04.034.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Frequency of new coronary events in older persons with peripheral arterial disease and serum low-density lipoprotein cholesterol > or = 125 mg/dl treated with statins versus no lipid-lowering drug.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献